节点文献
核因子κB 和转化生长因子β1在银杏叶提取物抗肝纤维化中的作用
Effects of nuclear factor (?)B and transforming growth factor β1 in the anti-liver fibrosis process using Ginkgo biloba extract
【摘要】 目的 观察银杏叶提取物(EGB)对大鼠肝纤维化的防治效果,探讨 EGB 抗肝纤维化的机 制。方法 采用四氯化碳诱导大鼠肝纤维化。EGB 各组四氯化碳处理同模型组,另分别给予0.25、0.5、 1.0g/kg EGB 灌胃。8周末检测其肝功能以及血清透明质酸和层黏连蛋白。取肝组织进行氧化应激测定,免 疫组织化学法检测核因子-kB(NF-kB)P65和α-平滑肌肌动蛋白的表达,逆转录聚合酶链反应法检 测转化生长因子β1(TGF β1)和Ⅰ型胶原 mRNA 的表达,凝胶电泳迁移率分析检测 NF-kB 的活性,并 进行病理组织学检查。结果 EGB 组肝纤维化分级评分、肝功能以及血清透明质酸和层黏连蛋白较模型组 明显改善;EGB 能抑制氧化应激、肝星状细胞的活化、NF-kB P65的表达以及 NF-kB 活性。此外,EGB 还可减低 TGF β1和Ⅰ型胶原 mRNA 的表达。结论 ECB 可能通过抑制氧化应激和 TGF β1的表达,减弱 NF-kB 诱导的肝星状细胞活化,从而阻止四氯化碳诱导的大鼠肝纤维化的发生发展。
【Abstract】 Objective To evaluate the effects of Ginkgo biloba extract(EGB)on CCl4-induced liver fibrosis and to investigate the underlying mechanisms.Methods Rats were divided into the following groups:normal control group, CC14 model group,low dose EGB group,moderate dose EGB group and high dose EGB group.The rat liver fibrosis model was induced by intraperitoneal injection of CC14 twice a week for 8 weeks.The rats of the three EGB treated groups were given 0.25 g/kg,0.5 g/kg,1.0 g/kg of EGB through stomach tubes every day.At the end of the eighth week,blood and liver specimens were obtained.The expressions of nuclear factor kappaB(NF-κB)P65,and α-smooth muscle actin(α- SMA)were detected by immunohistochemistry.Radioimmunoassay was used to evaluate serum hyaluronic acid(HA)and laminin(LN)levels.Electrophoretic mobility shift assay(EMSA)was used to confirm the nuclear translocation activity of NF-κB in liver tissues.The mRNA expression of transforming growth factor-β1(TGFβ1)and collagen I were determined by RT-PCR.Malondialdehyde(MDA),superoxide dismutase(SOD)and glutathione peroxidase(GSH-Px)in liver tissues and alanine aminotransferase(ALT)and aspartate aminotransferase(AST)in the sera were also examined. Results CC14 administration induced liver fibrosis,which was inhibited by EGB in a dose-dependent manner.The histopathologic scores of liver fibrosis,the levels of serum ALT,AST,HA and LN were significantly lower in the rats treated with EGB compared with those of the model group(P<0.01 or P<0.05).SOD and GSH-Px activites were notably elevated and MDA content was significantly lower in the rats treated with EGB(P<0.01 or P<0.05),indicating reduced oxidative stress.Immunohistochemical staining demonstrated inhibition of hepatic stellate cell(HSC)activation(in terms of α-SMA expression)and NF-κB P65 expression in the livers of the EGB-treated rats.As determined by EMSA and RT-PCR,activation of NF-κB,the mRNA expression of TGFβ1 and collagen I were significantly higher in model group rats.but obviously lower in EGB treated rats.Conclusion EGB is able to ameliorate liver injury and prevent rats from CCl4-induced liver fibrosis by suppressing oxidative stress This process may be related to inhibiting the expression of TGFβ1 and the induction of NF-κB on HSC activation.
【Key words】 Liver fibrosis; TGFβ1; NF-κB; Ginkgo biloba extract;
- 【文献出处】 中华肝脏病杂志 ,Chinese Journal of Hepatology , 编辑部邮箱 ,2005年12期
- 【分类号】R285
- 【被引频次】18
- 【下载频次】339